Mimedx (MDXG) Return on Capital Employed Growth (1y) (2012 - 2026)
Mimedx (MDXG) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | 2,400.00 |
| 10 | Mimedx | 646.48 Mn | 486.71 Mn | 41.62 Mn | -993.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -993.00 |
| Dec 31, 2025 | -429.00 |
| Sep 30, 2025 | -1,067.00 |
| Jun 30, 2025 | -1,544.00 |
| Mar 31, 2025 | -291.00 |
| Dec 31, 2024 | 617.00 |
| Sep 30, 2024 | 876.00 |
| Jun 30, 2024 | 2,252.00 |
| Mar 31, 2024 | 3,140.00 |
| Dec 31, 2023 | 3,354.00 |
| Sep 30, 2023 | 4,350.00 |
| Jun 30, 2023 | 2,544.00 |
| Mar 31, 2023 | 210.00 |
| Dec 31, 2022 | -649.00 |
| Sep 30, 2022 | -263.00 |
| Jun 30, 2022 | 995.00 |
| Mar 31, 2022 | 2,074.00 |
| Dec 31, 2021 | 2,560.00 |
| Sep 30, 2021 | 1,019.00 |
| Jun 30, 2021 | -1,263.00 |